$58.22
2.013.58%
At close: -
$58.50
0.280.48%
After Hours: 4:31 PM EDT
Comments
Loading...
Belite Bio (BLTE) Forecast
NewsEarningsBelite Bio (BLTE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBelite Bio (NASDAQ:BLTE) Stock Quotes, Forecast and News Summary
Belite Bio Stock (NASDAQ: BLTE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Belite Bio (BLTE) stock?
You can purchase shares of Belite Bio (NASDAQ:BLTE) through any online brokerage.
Who are Belite Bio (BLTE) competitors?
Other companies in Belite Bio’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and ANI Pharmaceuticals (NASDAQ:ANIP).
What is the forecast, or price target, for Belite Bio (BLTE) stock?
Belite Bio has a consensus price target of $78.50.
What is the current price for Belite Bio (BLTE)?
The stock price for Belite Bio (NASDAQ: BLTE) is $58.5 last updated January 21, 2025 at 4:31 PM EST.
Does Belite Bio (BLTE) pay a dividend?
There are no upcoming dividends for Belite Bio.
When is Belite Bio (NASDAQ:BLTE) reporting earnings?
Belite Bio’s Q4 earnings are confirmed for Monday, March 10, 2025.
Is Belite Bio (BLTE) going to split?
There is no upcoming split for Belite Bio.
What sector and industry does Belite Bio (BLTE) operate in?
Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.